Patents by Inventor Elisabeth De Vries

Elisabeth De Vries has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POSITRON EMISSION TOMOGRAPHY IMAGING OF ACTIVATABLE BINDING POLYPEPTIDES AND RELATED COMPOSITIONS THEREOF
    Publication number: 20200405890
    Abstract: The present invention provides methods, compounds, and compositions useful for determining the biodistribution of an activated binding polypeptide in a mammalian subject. The present invention also provides methods for identifying mammalian subjects suitable for treatment with an activatable binding polypeptide.
    Type: Application
    Filed: February 21, 2019
    Publication date: December 31, 2020
    Inventors: Olga VASILJEVA, Emma Geertruida Elisabeth DE VRIES, Marjolijn N. LUB-DE HOOGE, Annelies JORRITSMA-SMIT, Martin POOL, Danique GIESEN, Iris KOK, Linda BROER, Mark STROH
  • Methods and compositions for treating disorders
    Patent number: 10064963
    Abstract: The present disclosure relates to a method of treating, ameliorating or preventing a disorder by blocking the signaling pathway of c-Met, wherein said method comprises the step of administering a therapeutically effective amount of a composition to a subject in need thereof, which composition contains a lipocalin mutein or a fragment or a variant thereof. In addition, the present disclosure relates to a diagnostic composition suitable for use in, e.g., an immuno-imaging technique to detect the presence of c-Met as well as the uses thereof.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: September 4, 2018
    Assignee: PIERIS PHARMACEUTICALS GMBH
    Inventors: Shane Olwill, Hendrik Gille, Laurent Audoly, Marlon Hinner, Elisabeth De Vries, Anton G. T. Terwisscha Van Scheltinga
  • METHODS FOR PREVENTING, TREATING OR DIAGNOSING DISORDERS
    Publication number: 20150004098
    Abstract: The present disclosure relates to a method of treating, ameliorating or preventing a disorder by blocking the signaling pathway of c-Met, wherein said method comprises the step of administering a therapeutically effective amount of a composition to a subject in need thereof, which composition contains a lipocalin mutein or a fragment or a variant thereof. In addition, the present disclosure relates to a diagnostic composition suitable for use in, e.g., an immuno-imaging technique to detect the presence of c-Met as well as the uses thereof.
    Type: Application
    Filed: January 7, 2013
    Publication date: January 1, 2015
    Inventors: Shane Olwill, Hendrik Gille, Laurent Audoly, Marlon Hinner, Elisabeth De Vries, Anton G.T. Terwisscha Van Scheltinga